ArticleUrology case reports2025

Robust response to pembrolizumab plus lenvatinib in a patient with renal cell carcinoma with rhabdoid features: A case report.

Shinkuro Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.